0439 Info.pdf (129.29 kB)
Download fileInfographic – Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors
figure
posted on 2022-06-14, 15:24 authored by Figshare Future Science GroupFigshare Future Science Group, Mercedes Porosnicu, Anne-Marie Quinson, Kate Crossley, Stephan Luecke, Ulrich M LauerPhase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors
